Prasugrel may be safe for further testing in people undergoing PCI. Commentary

Affiliations

Comment

Steven R Steinhubl. Evid Based Cardiovasc Med. 2005 Dec.

. 2005 Dec;9(4):301-4.

doi: 10.1016/j.ebcm.2005.09.049. Epub 2005 Nov 2.

No abstract available

Comment on

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial.
Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, Carney RJ, Lazzam C, McKay RG, McCabe CH, Braunwald E; JUMBO-TIMI 26 Investigators. Wiviott SD, et al. Circulation. 2005 Jun 28;111(25):3366-73. doi: 10.1161/CIRCULATIONAHA.104.502815. Epub 2005 Jun 20. Circulation. 2005. PMID: 15967851 Clinical Trial.